Koninklijke Philips NV, together with a consortium of partners, has secured a EUR 23.5 million grant from the Innovative Health Initiative $(IHI)$ to support a five-year research program focused on developing next-generation minimally invasive brain treatments. The SEISMIC consortium, coordinated by Philips and with Erasmus MC as the academic lead, will combine advanced medical imaging and minimally invasive techniques to improve the treatment of brain bleeding and tumors. The total project budget is EUR 38.4 million, with additional in-kind contributions and resources from industry partners. Other beneficiaries include industry partners such as Oldelft Ultrasound, DEMCON Curix, Yaskawa, us4us, Caresyntax, Surgical Science, Boston Scientific, and Bracco; patient organizations Fundacio Ictus and Cancer Patients Europe; and academic partners including Erasmus University Rotterdam, University Medical Center Utrecht (UMCU), Radboud University Medical Center (Radboudumc), Hospital Clinic Barcelona (including IDIBAPS), Vall d'Hebron University Hospital/Vall d'Hebron Research Institute (VHIR), and University of Ljubljana.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royal Philips NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: OMX_____GNW1001164133-en) on February 11, 2026, and is solely responsible for the information contained therein.